In a new study published in Nature Communications, researchers at Karolinska Institutet show that mucosa-associated invariant T cells (MAIT cells) of the human immune system respond with dynamic activity and reprogramming ...
Jan 14, 2020
0
20
(HealthDay)—The prevalence of neural tube defects (NTDs) is 7.0 per 10,000 live births in HIV-exposed pregnancies, which is similar to the prevalence in the general population, according to research published in the Jan. ...
Jan 10, 2020
0
2
Ever since antiretroviral treatments against HIV infection were introduced in 1996, scientists have eagerly been hunting for a cure for the disease.
Jan 9, 2020
0
700
The most effective way to reduce HIV-related deaths and prevent onward transmission is to diagnose and treat all persons as soon as possible after HIV infection. According to a study published in Clinical Infectious Diseases, ...
Jan 8, 2020
0
4
A review of more than 100 studies from around the world has shown that people who use opioids for extramedical reasons have significantly higher rates of mortality.
Jan 7, 2020
0
9
University researchers finds that scaling up use of methadone and buprenorphine—medications for treating opioid use disorder known as opioid agonist therapies (OATs)—could greatly reduce HIV transmission rates and prevent ...
Jan 3, 2020
0
13
The search for an AIDS cure has partly focused on ways to eradicate infected cells. Now, new research from Karolinska Institutet in Sweden and the University of Pennsylvania in the U.S. shows that this approach may not be ...
Dec 18, 2019
0
44
A new peer-reviewed commentary published in the January issue of the American Journal of Public Health argues for new metrics to evaluate the public health response to HIV in the United States. The U.S. Department of Health ...
Dec 17, 2019
0
1
A major goal of tuberculosis (TB) research is to find a way to treat people with the latent (or inactive) form of the disease to keep them from developing symptomatic TB. A breakthrough study using a new animal model developed ...
Dec 17, 2019
0
54
Microbes living in the rectum could make a difference to the effectiveness of experimental HIV vaccines, according to researchers at the University of California, Davis. The work is published Dec. 11 in the journal mSphere.
Dec 13, 2019
0
15
